FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "QuVa Pharma, Inc.(080064259)" | Fentanyl Citrate | 60 mg/3 L | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Fentanyl Citrate | 250 mg/500 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Fentanyl Citrate | 30 mg/3 L | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Fentanyl Citrate | 30 mg/3 L | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Fentanyl Citrate | 1 g/2 L | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Hydromorphone Hydrochloride | 600 mg/3 L | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Hydromorphone Hydrochloride | 1500 mg/3 L | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Hydromorphone Hydrochloride | 3000 mg/3 L | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ketamine Hydrochloride | 75 g/1500 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ketamine Hydrochloride | 30 g/3 L | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ketamine Hydrochloride | 30 g/3 L | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ketamine Hydrochloride | 30 g/3 L | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ketamine Hydrochloride | 25 g/500 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Labetalol Hydrochloride | 15 g/3 L | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Lidocaine Hydrochloride Anhydrous | 3334 mg/2 L | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "RXQ Compounding, LLC(079640811)" | 70731-971 | 70731-971-10 | Ascorbic Acid; Glutathione | 20 mg/1 mL; 200 mg/1 mL | 2021-1 | valid | 2026-11-12 | ||
| "RXQ Compounding, LLC(079640811)" | 70731-906 | 70731-906-30 | Ascorbic Acid; Glutathione | 20 mg/1 mL; 200 mg/1 mL | 2021-1 | valid | 2026-11-12 | ||
| "RXQ Compounding, LLC(079640811)" | 70731-961 | 70731-961-82 | Niacinamide; Riboflavin 5'-Phosphate Sodium; Dexpanthenol; Thiamine Hydrochloride; Pyridoxine Hydrochloride | 100 mg/1 mL; 2.54 mg/1 mL; 5 mg/1 mL; 100 mg/1 mL; 2 mg/1 mL | 2021-1 | valid | 2026-11-12 | ||
| "RXQ Compounding, LLC(079640811)" | 70731-136 | 70731-136-86 | Phenylephrine Hydrochloride | 100 ug/1 mL | 2021-1 | valid | 2026-11-12 | ||
| "RXQ Compounding, LLC(079640811)" | 70731-956 | 70731-956-30 | Pyridoxine Hydrochloride | 100 mg/1 mL | 2021-1 | valid | 2026-11-12 | ||
| "RXQ Compounding, LLC(079640811)" | 70731-238 | 70731-238-41 | Ropivacaine Hydrochloride | 2 mg/1 mL | 2021-1 | valid | 2026-11-12 | ||
| "RXQ Compounding, LLC(079640811)" | 70731-201 | 70731-201-85 | Ephedrine Sulfate | 5 mg/1 mL | 2021-1 | valid | 2026-11-12 | ||
| "RXQ Compounding, LLC(079640811)" | 70731-231 | 70731-231-86 | Epinephrine | 10 ug/1 mL | 2021-1 | valid | 2026-11-12 | ||
| "RXQ Compounding, LLC(079640811)" | 70731-118 | 70731-118-55 | Fentanyl Citrate | .05 mg/1 mL | 2021-1 | valid | 2026-11-12 | ||
| "RXQ Compounding, LLC(079640811)" | 70731-246 | 70731-246-55 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2021-1 | valid | 2026-11-12 | ||
| "RXQ Compounding, LLC(079640811)" | 70731-916 | 70731-916-50 | Ascorbic Acid | 500 mg/1 mL | 2021-1 | valid | 2026-11-12 | ||
| "RXQ Compounding, LLC(079640811)" | 70731-975 | 70731-975-50 | Ascorbic Acid | 500 mg/1 mL | 2021-1 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .02 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Magnesium Sulfate Heptahydrate | 2 g | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Midazolam Hydrochloride | 1 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Midazolam Hydrochloride | 1 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Midazolam Hydrochloride | 1 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Midazolam Hydrochloride | 1 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Atropine Sulfate | .4 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Morphine Sulfate | 2 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Morphine Sulfate | 5 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Morphine Sulfate | 1 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Morphine Sulfate | 1 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Morphine Sulfate | 1 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Morphine Sulfate | 1 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Morphine Sulfate | 1 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Morphine Sulfate | 1 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Morphine Sulfate | 1 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Morphine Sulfate | 1 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Neostigmine Methylsulfate | 1 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Norepinephrine Bitartrate | .016 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Norepinephrine Bitartrate | .016 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Norepinephrine Bitartrate | .032 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Norepinephrine Bitartrate | .064 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Oxytocin | 30 [USP'U] | 2021-1 | source_no_ndc | 2026-11-12 |